Tengion Overview
- Founded
-
2003
- Status
-
Public
- Employees
-
40
- Stock Symbol
-
TNGNQ
Tengion General Information
Description
Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace damaged tissue or organ. Its product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. The company's solution Neo-Kidney Augment is based on its proprietary technology, which uses tubular epithelial cells, procured by a cortical biopsy of the patient's kidney, to create an injectable product candidate that can catalyze the regeneration of functional kidney tissue.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
GREY
Primary Office
- 3929 Westpoint Boulevard
- Suite G
- Winston-Salem, NC 27103
- United States
Tengion Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 34.5K |
Tengion Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2014 | FY 2013 31-Dec-2013 | FY 2012 31-Dec-2012 | FY 2011 31-Dec-2011 |
|---|---|---|---|---|
| EV | 21,804 | 2,588 | 6,175 | (2,938) |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (56,419) | (11,085) | (13,543) | (15,124) |
| Net Income | (64,426) | (18,927) | (16,929) | (19,061) |
| Total Assets | 9,621 | 25,724 | 12,435 | 17,817 |
| Total Debt | 34,122 | 26,952 | 11,269 | 4,987 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Tengion Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tengion Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing
Biotechnology
Winston-Salem, NC
40
As of 2014
00000
00000000000
000000
ua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a
0000000000000
Marietta, GA
000
As of 0000
00000
000000000
00000
000000
uip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
0000000000000
Rancho Cordova, CA
00
As of 0000
000.00
00000000
000.00
Add Comparison
Tengion Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mimedx | Corporation | Marietta, GA | 000 | 00000 | 000000000 | 00000 |
| 0000000000000 0000 | Corporation | Rancho Cordova, CA | 00 | 000.00 | 00000000 | 000.00 |
Tengion Patents
Tengion Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2011224448-A1 | Cell-scaffold constructs | Inactive | 09-Mar-2010 | 00000000000 | |
| US-20110224800-A1 | Cell-scaffold constructs | Inactive | 09-Mar-2010 | 00000000000 | 00 |
| CA-2791736-A1 | Cell-scaffold constructs | Inactive | 09-Mar-2010 | 00000000000 | |
| EP-2544726-A1 | Cell-scaffold constructs | Inactive | 09-Mar-2010 | 00000000000 | |
| US-20110123455-A1 | Rational design of regenerative medicine products | Inactive | 12-Nov-2009 | G01N33/5088 |
Tengion Executive Team (11)
Tengion Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000-00000 0000000 | Self | Board Member | 000 0000 |
| 00000 000000 | Tengion | Chairman & Board Member | 000 0000 |
| 00000 00000000 00 | Self | Board Member | 000 0000 |
| 0000 000000 | Tengion | Chief Executive Officer & Board Member | 000 0000 |
| 00000 0000000 | Self | Board Member | 000 0000 |
Tengion Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
